Jump to Header Jump to Main Content Jump to Footer

Ph I Study of IGM-8444 as a Single Agent & in Combo in Subjects w/ Relapsed &/or Refr Solid Cancers

Warren A Chow


A Study On:

  • Small Intestine
  • Anus
  • Lung
  • Corpus Uteri
  • Kidney
  • Eye and Orbit
  • Stomach
  • Other Urinary
  • Other Endocrine System
  • Esophagus
  • Liver
  • Mycosis Fungoides
  • Ovary
  • Urinary Bladder
  • Breast
  • Kaposi's Sarcoma
  • Prostate
  • Melanoma, Skin
  • Pancreas
  • Other Skin
  • Other Male Genital
  • Unknown Sites
  • Colon
  • Bones and Joints
  • Cervix
  • Other Female Genital
  • Ill-Defined Sites
  • Lip, Oral Cavity and Pharynx
  • Larynx
  • Other Respiratory and Intrathoracic Organs
  • Soft Tissue
  • Thyroid
  • Rectum
  • Other Digestive Organ
  • Brain and Nervous System

Status:

  • Open

Eligibility

Adult

Official Title

An Open-label, Multicenter, Phase Ia/Ib Study of IGM-8444 as a Single Agent and in Combination in Subjects With Relapsed, Refractory, or Newly Diagnosed Cancers


Eligibility

You can join if...

You can participate in this study if you are at least 18 years of age or older; have been clinically diagnosed with of locally advanced or metastatic cancer. You cannot participate in this study if you are pregnant or breast feeding; if you are using medication well known to cause liver toxicity.

Get in touch with our study team